Ted Love | President and CEO |
Jeff Farrow | Chief Financial Officer |
David Johnson | Chief Commercial Officer |
Kim Smith-Whitley | EVP and Head of R&D |
Steven Immergut | SVP, Head of Corporate Communications and IR |
Brian Cathers | Chief Scientific Officer |
Jason Gerberry | Bank of America |
Akash Tewari | Jefferies |
Alethia Young | Cantor Fitzgerald |
Mark Breidenbach | Oppenheimer |
Paul Choi | Goldman Sachs |
Joon Lee | Truist Securities |
Gregory Renza | RBC Capital Markets |
Matthew Harrison | Morgan Stanley |
Maneka Mirchandaney | Evercore |
Ritu Baral | Cowen and Company |
Yatin Suneja | Guggenheim Partners |
Ben Burnett | Stifel |
Danielle Brill | Raymond James |
Andreas Argyrides | Wedbush Securities |
Yanan Zhu | Wells Fargo |
Greetings, and welcome to the Global Blood Therapeutics Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the prepared remarks. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Steven Immergut.